Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 31, 2017
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Award
Common Stock
2017-01-09+1,650→ 33,594 total - Award
Options to Purchase Common Stock
2017-01-09+2,750→ 2,750 totalExercise: $3.54From: 2018-01-09Exp: 2027-01-09→ Common Stock (2,750 underlying)
Holdings
- 8,434(indirect: By IRA)
Common Stock
- 1,954(indirect: By Trust)
Common Stock
- 802(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents 1,650 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018.
- [F2]Includes 2,775 shares of unvested restricted stock granted under the Issuer's compensation plans.